Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-HIV cellular therapy based on dendritic cells pulsed with chemically inactivated virus
NCT02766049Phase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Feb 2010
- Primary completion
- May 2014
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
A Phase 2 trial of autologous dendritic cells pulsed with AT-2-inactivated HIV in human immunodeficiency virus infection (HIV), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Feb 2010; status: completed.
02
Drugs
autologous dendritic cells pulsed with AT-2-inactivated HIV
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02766049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02766049.